Surgery Partners

Leverage And CMS Shifts Will Curb Earnings Yet Spark Recovery

AnalystLowTarget

Not Invested

Consensus Narrative from 11 Analysts

Published

04 Sep 25

AnalystLowTarget's Fair Value

US$24.00

8.9% undervalued

04 Sep

US$21.87

-29.5%

-2.8%

-29.5%

-2.8%

Edit anytime before Sep 4 10:43 PM. Then post Updates to your followers.

Author's Valuation

US$24.0

8.9% undervalued

AnalystLowTarget Fair Value

Narrative

Updates0

AnalystLowTarget Fair Value

US$24

8.9% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

8.89%

Healthcare Services revenue growth rate

0.24%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

7.86%

Calculation

US$24.20m

Earnings '28

161.00x

PE Ratio '28

US$3.90b

Market Cap '28

US$3.90b

Market Cap '28

130.18m

No. shares '28

US$29.93

Share Price '28

US$29.93 Share Price '28

Discounted to 2025 @ 7.68% p.a.

US$23.97

Fair Value '25